Retension Pharmaceuticals, Inc. · NASDAQ:RTSN
Sweetnam Paul converted 6,666 Retension Pharmaceuticals, Inc. shares (Form 4)
Traded Oct 13, 2026 · Filed Oct 13, 2026
On Oct 13, 2026, Sweetnam Paul (CHIEF SCIENTIFIC OFFICER) converted 6,666 Retension Pharmaceuticals, Inc. shares, leaving 2,640 shares. Filed Oct 13, 2026 (Form 4).
- Converted
- 6,666 shares
- Holding after
- 2,640 shares (held indirectly)
- Trading plan
- No
- Role
- CHIEF SCIENTIFIC OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | Common Stock | Conversion | 4,026 | 406,603 | Direct | |
| Oct 13, 2026 | Common Stock | Conversion | 2,640 | 2,640 | Indirect |
Source
Related
- Retension Pharmaceuticals, Inc.
- Sweetnam Paul
- Retension Pharmaceuticals, Inc. shareholders
- Schedule 13G · Pvg Asset Management Corp · Oct 16, 2026
- Schedule 13G · B Group, Inc. · Oct 16, 2026
- Schedule 13G · Laurence W. Lytton · Oct 15, 2026
- Schedule 13D · Keller Eric L. · Oct 14, 2026
- Form 4 · Berendt Michael J · Oct 13, 2026